Previously, a lower expression of FCN3 has been found and proved either in tissue or serum from numerous cancer patients such as ovarian cancer, multiple myeloma, lymphoma, acute myeloid leukemia, head and neck cancer, and lung cancer 8,10-15. The gene discussed is FCN3; the disease is cancer.